Covariate data for new set of controls for GWAS studies |
Rachael Stolzenberg-Solomon |
DCEG, NCI |
PLCO |
Mar 27, 2024 |
PLCO-1515 |
Enhancing Lung Cancer Treatment Decisions through AI-driven Analysis of PLCO Patient Data |
Ricardo Gonzales Vera |
University of Oxford |
PLCO |
Mar 27, 2024 |
PLCO-1514 |
Adherence to the EAT-Lancet dietary pattern reduces the risk of renal cancer in the PLCO Cancer Screening Trial |
Linglong Peng |
The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. |
PLCO |
Mar 27, 2024 |
PLCO-1513 |
Identifying novel genetic factors predisposing to inherited cardiac disorders |
Connie Bezzina |
Amsterdam Universitair Medisch Centrum |
PLCO |
Mar 25, 2024 |
PLCO-1507 |
Anthocyanin and ovarian cancer risk: a prospective study in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort |
Huijun Huang |
Wenzhou medical university |
PLCO |
Mar 25, 2024 |
PLCO-1506 |
Lung and Cardiovascular Disease Detection with Large Scale, Disease Screening Chest X-rays |
Pingkun Yan |
Rensselaer Polytechnic Institute |
PLCO |
Mar 25, 2024 |
PLCOI-1505 |
Check if CXR can be implemented as a biomarker for aging. |
changduk Seo |
Kyungpook National University |
PLCO |
Mar 15, 2024 |
PLCOI-1497 |
Early Detection of Breast Cancer with AI enhanced workflows |
Dr. Tariq Mahmood |
Institute of Business Administration |
PLCO |
Mar 13, 2024 |
PLCO-1496 |
Association between adherence to Eat-Lancet diet and incidence and mortality of liver cancer: A prospective cohort study |
Lifu Lei |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Mar 11, 2024 |
PLCO-1491 |
Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification |
Corey Arnold |
University of California, Los Angeles |
PLCO |
Mar 11, 2024 |
PLCOI-1492 |
Assess positive-sum fairness of CXR classifiers leveraging demographic attributes |
Samia Belhadj |
Lunit Inc. |
PLCO |
Feb 27, 2024 |
PLCO-1490 |
Alcohol intake and the risk of colorectal adenomas and colorectal cancer in the PLCO (NCI Version) |
Erikka Loftfield |
(240)762-3319 |
PLCO |
Feb 27, 2024 |
PLCO-1489 |
Artificial Intelligence-Based Pathological Model for Predicting Biochemical Recurrence in Prostate Cancer: a Multicenter Study |
Rui Chen |
Shanghai Jiao Tong University School of Medicine |
PLCO |
Feb 26, 2024 |
PLCOI-1486 |
Ethnic and molecular diversity in prostate cancer |
Lisa Smith |
University of Nebraska at Omaha |
PLCO |
Feb 26, 2024 |
PLCO-1488 |
Characterizing polyp progression and its relationship to colorectal cancer in a longitudinal study |
Scott Lipnick |
Flagship Labs LLC |
PLCO |
Feb 26, 2024 |
PLCO-1485 |
Development of Medical AI for Cancer Diagnosis and Area Detection |
hyunwoo kim |
VUNO |
PLCO |
Feb 26, 2024 |
PLCOI-1484 |
Development of non-invasive biomarkers to assess disease progression using patients diagnostic imaging and clinical data |
Yoganand Balagurunathan |
H Lee Moffitt Cancer Center and Research Institute |
PLCO |
Feb 26, 2024 |
PLCOI-1469 |
Is there a correlation between the age of the diagnosed prostate cancer patient and initial PSA result and final staging |
Alistair Wright |
Open University |
PLCO |
Feb 26, 2024 |
PLCO-1482 |
Examining the performance of weighting methods under different populations |
Lei Song |
George Washington University |
PLCO |
Feb 15, 2024 |
PLCO-1480 |
The Impact of Location of Colon Polyps at Colonoscopy on Risk of Colorectal Cancer Incidence and Mortality: Secondary Analyses of the PLCO Trial |
Paolo Goffredo |
University of Minnesota |
PLCO |
Feb 14, 2024 |
PLCO-1465 |